MEDI-528 is a humanized antibody targeting IL-9, which is a member of a family of inflammatory signaling molecules known as interleukins. Several of these interleukin molecules, including IL-9,
Shire stated that the FDA approved Intuniv on September 2, 2009 as an ADHD treatment for children and adolescents ages 6 to 17, based on two pivotal monotherapy
Sohm said that the sales are expected to begin in Uganda, Tanzania, and Zambia under the Sohm brand as soon as the necessary measures have been completed in
StemDisc is Shrink’s latest bioscience application of its proprietary, patent-pending, advanced plastic material called NanoShrink. Shrink has claimed that StemDisc offers a low cost, flexible and cost effective
FDA issued Import Alert no 66-38, ‘Skin Care Products Labeled As Anti-Aging Creams’ (IA 66-38) in 1988, subjecting cosmetic manufacturers, including several large, non-US cosmetics importers Estee Lauder,
Shimadzu and bioMerieux have said that the new solution is planned for commercialisation by bioMerieux in 2010, together with the microbial database acquired from AnagnosTec. Shimadzu has developed
PerkinElmer and Abbott’s presentation will be based on their work together incorporating PerkinElmer’s exact mass TOF technology as part of Abbott’s Plex-ID detection platform, employed in pathogen detection
Can-Fite claimed that its CF101 is a targeted drug that specifically attacks diseased or pathologic cells without compromising normal body systems, and therefore has shown a favorable safety
Ortho-McNeil Pharmaceutical is said to have been used promotional program called the ‘Doctor for a Day Program’ to promote its epilepsy drug, Topamax to psychiatrists, including some in
PPJ Enterprise has planned to enhance, update to compliance and start to market the software during the year of 2010. It has been looking for equity partners and/or
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.